Popular GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight, but what should patients know about ...

A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...

Zepbound outperformed Wegovy for weight loss in a new clinical trial funded by Eli Lilly & Co., Zepbound's maker.

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?

Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating ...

Leah Rae Russell lost more than 200 pounds over a decade, but she says she wasn’t able to fully appreciate her accomplishment until she took a final step: tightening and removing about 3 pounds of ...

A new crop of evidence — both anecdotal and research based — is pointing to these drugs as a potential option for people ...

The trial, known as SURMOUNT-5, found that participants using Zepbound lost an average of 20.2% of their body weight, while ...

Eli Lilly and Company has announced topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial.

MILLIONS of Brits “will have to wait” to take a lifesaving fat loss jab dubbed the “King Kong of weight loss drugs”. Fewer ...

Mounjaro will be made available on the NHS but the rollout will be phased - only those with the highest need will get the ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...